ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Net Income

Bottom-line profit, the starting point for calculating cash from operations.

No reported Net Income figures are available to summarize.

Net Income history

Currency unavailable · from the cash flow

No Net Income data reported for this period type.

Net Income vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Net Income for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MGTXMeiraGTx Holdings plcLTM Mar 2026$328.6M USD+96.4%-4.1%412.0%
PRMEPrime Medicine, Inc.LTM Mar 2026$198.37M USD-1.8%+18.2%4917.6%
WVEWave Life Sciences Ltd.LTM Mar 2026$183.59M USD+63.4%+8.1%255.7%
STOKStoke Therapeutics, Inc.LTM Mar 2026$169.77M USD-437.7%-59.2%529.2%
SLNSilence Therapeutics plcLTM Mar 2026$145.44M USD—+20.7%15782.6%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$78.67M USD+15.4%—173.5%
RNAAtrium Therapeutics, Inc.FY2025$49.5M USD——265.9%
PRQRProQR Therapeutics N.V.LTM Mar 2026€45.62M EUR+51.2%-14.2%339.4%
BNTCBenitec Biopharma Inc.LTM Mar 2026$41.54M USD+56.8%+27.7%—
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+51.2%+8.1%375.7%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.